How to use Trastuzumab injection (subcutaneous injection) (Herceptin Hylecta)

Before using Trastuzumab injection (subcutaneous injection ) (Herceptin Hylecta) for treatment, you need to clarify whether you need this drug for treatment, because it is only for one-time use by subcutaneous injection and cannot replace other versions of drug treatment. 600mg/10000 units (600mg trastuzumab and 10000 units hyaluronidase) solution is a ready-to-use injection without dilution.

To avoid needle clogging, attach the hypodermic needle to the syringe immediately before administration and adjust the volume to 5 mL. Prepare administration syringes under controlled and validated sterile conditions. Injection sites should alternate between the left and right thighs. The new injection should be given on healthy skin at least 2.5 cm away from the old previous site and not into areas of red, bruised, tender or hardened skin, or areas with moles or scars. During treatment with Trastuzumab Injection (subcutaneous injection) , other pharmaceutical products intended for subcutaneous administration should preferably be injected at a different site. The dose should be administered subcutaneously in approximately 2-5 minutes, usually every 3 weeks. The length of treatment will depend on the patient's condition and the body's response to treatment.

It is understood that the original drug of trastuzumab injection (subcutaneous injection) has been launched in China, but the specific price and other relevant information are not yet clear. Since the drug has been on the market for a short time, it has not been included in the scope of medical insurance. At present, there are no generic drugs of Trastuzumab injection (subcutaneous injection) produced and marketed. For more information and specific prices of Trastuzumab injection (subcutaneous injection), please consult a medical consultant.